Comparison of Dydrogesterone and Micronized Progesterone Treatments in the Treatment of Threatened Miscarriage.

NCT05542797 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2022-09-15

No results posted yet for this study

Summary

In this study, we aimed to compare the effects of two drugs used for the threated miscarriage on the miscarriage rate.

Conditions

  • Miscarriage Threatening

Interventions

DRUG

Duphastone

dydrogesterone hormone

Sponsors & Collaborators

  • Konya Meram State Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-31
Primary Completion
2023-10-31
Completion
2024-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05542797 on ClinicalTrials.gov